| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 584.516 | 298.074 | 393.535 | 314.019 | 285.639 | 358.170 | 378.661 | 428.713 | 401.189 | 442.761 |
| Total Income - EUR | 590.422 | 316.147 | 394.328 | 318.246 | 294.490 | 358.182 | 382.959 | 430.567 | 401.307 | 442.774 |
| Total Expenses - EUR | 559.325 | 357.633 | 388.125 | 328.655 | 288.417 | 313.780 | 351.141 | 404.921 | 394.168 | 435.265 |
| Gross Profit/Loss - EUR | 31.097 | -41.487 | 6.204 | -10.410 | 6.073 | 44.402 | 31.818 | 25.646 | 7.139 | 7.509 |
| Net Profit/Loss - EUR | 22.211 | -41.487 | 1.243 | -13.594 | 3.120 | 41.006 | 28.088 | 21.422 | 3.727 | -5.782 |
| Employees | 6 | 5 | 5 | 6 | 5 | 5 | 5 | 5 | 5 | 4 |
Check the financial reports for the company - Alemi Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 35.581 | 18.015 | 15.195 | 20.950 | 6.654 | 5.506 | 32.565 | 26.368 | 16.984 | 9.109 |
| Current Assets | 269.128 | 104.454 | 100.209 | 72.232 | 51.279 | 80.084 | 88.364 | 96.565 | 85.257 | 81.991 |
| Inventories | 45.355 | 32.156 | 50.448 | 31.485 | 25.514 | 43.170 | 31.118 | 36.941 | 36.210 | 31.529 |
| Receivables | 223.370 | 70.292 | 58.255 | 47.677 | 25.475 | 32.235 | 24.956 | 50.774 | 33.902 | 30.845 |
| Cash | 403 | 2.006 | -8.495 | -6.930 | 290 | 4.679 | 32.290 | 8.849 | 15.145 | 19.617 |
| Shareholders Funds | 90.896 | 24.340 | -22.643 | -39.893 | -36.000 | 5.689 | 28.330 | 21.665 | 5.110 | -5.541 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 213.813 | 98.130 | 138.047 | 133.074 | 93.934 | 79.901 | 92.599 | 101.268 | 97.131 | 96.642 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Alemi Pharma Srl